1. Home
  2. ES vs IQV Comparison

ES vs IQV Comparison

Compare ES & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eversource Energy (D/B/A)

ES

Eversource Energy (D/B/A)

HOLD

Current Price

$68.47

Market Cap

25.1B

Sector

Utilities

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$160.91

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ES
IQV
Founded
1927
1982
Country
United States
United States
Employees
N/A
93000
Industry
Electric Utilities: Central
Biotechnology: Commercial Physical & Biological Resarch
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.1B
28.6B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
ES
IQV
Price
$68.47
$160.91
Analyst Decision
Hold
Strong Buy
Analyst Count
11
16
Target Price
$71.00
$227.13
AVG Volume (30 Days)
1.8M
1.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
4.70%
N/A
EPS Growth
100.88
4.67
EPS
4.56
7.84
Revenue
$13,547,244,000.00
$9,739,000,000.00
Revenue This Year
N/A
$6.77
Revenue Next Year
$3.77
$5.89
P/E Ratio
$14.67
$22.35
Revenue Growth
13.83
41.60
52 Week Low
$56.70
$134.65
52 Week High
$76.41
$247.05

Technical Indicators

Market Signals
Indicator
ES
IQV
Relative Strength Index (RSI) 44.66 36.34
Support Level $64.91 $159.42
Resistance Level $68.84 $193.26
Average True Range (ATR) 1.25 6.17
MACD -0.07 -0.11
Stochastic Oscillator 35.12 4.19

Price Performance

Historical Comparison
ES
IQV

About ES Eversource Energy (D/B/A)

Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric, gas, and water distribution service to more than 4 million customers in the Northeast US. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. It plans to sell Aquarion in 2026. The company exited most of its unregulated businesses in 2006.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: